Related Experiment Video
Updated: Mar 3, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Target Blood Pressure in Elderly Hypertensive Patients: How Low Should You Go?
1a Centro di Fisiologia Clinica e Ipertensione, Via F Sforza 35, 20122 Milan, Italy.
Insights
Hypertension is common in older adults and increases cardiovascular risk. Antihypertensive treatment effectively lowers this risk, with intensive therapy showing greater blood pressure reduction in the elderly without increased adverse events.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Hypertension prevalence increases with age, elevating cardiovascular disease (CVD) risk.
- Antihypertensive treatment in elderly patients significantly reduces CVD mortality and morbidity.
- Treatment benefits correlate with the degree of blood pressure reduction.
Purpose of the Study:
- To review the efficacy and safety of antihypertensive therapies in elderly patients.
- To discuss the role of intensive blood pressure lowering in this demographic.
- To highlight new therapeutic options like angiotensin II type 1 receptor antagonists.
Main Methods:
- Analysis of epidemiological data and randomized controlled trials (RCTs).
- Review of findings from the Hypertension Optimal Treatment (HOT) Study.
- Examination of ongoing trials like the Study on Cognition and Prognosis in the Elderly (SCOPE).
Main Results:
- Intensive antihypertensive therapy in the elderly yields greater blood pressure reduction than in younger patients.
- No increased risk of adverse events was observed with intensive therapy in elderly individuals.
- Current guidelines recommend targeting high-normal blood pressure (below 140/90 mmHg) in elderly patients.
Conclusions:
- Aggressive blood pressure control is recommended for elderly hypertensive patients.
- Angiotensin II type 1 receptor antagonists represent a promising therapeutic avenue.
- Further research, including trials like SCOPE, is crucial to confirm long-term outcomes.
Abstract:
Epidemiological studies have highlighted the increasing prevalence of hypertension with age, and the associated increase in the risk of cardiovascular disease. A number of randomized controlled trials have shown that antihypertensive treatment significantly reduces cardiovascular mortality and morbidity in elderly patients, and there is evidence that the benefit achieved is related to the extent to which blood pressure is lowered. Furthermore, a recent analysis of data from the Hypertension Optimal Treatment (HOT) Study shows that intensive therapy produces significantly greater reductions in blood pressure in elderly patients than in younger patients, without increasing the risk of adverse events. As a result, the latest management guidelines recommend that the goal of antihypertensive therapy in elderly patients should be to achieve at least high normal blood pressures (below 140/90 mmHg). Angiotensin II type 1 receptor antagonists offer a new option for antihypertensive therapy in elderly patients, and trials such as the Study on Cognition and Prognosis in the Elderly (SCOPE) are currently investigating the effect of these agents on cardiovascular mortality and morbidity in elderly hypertensive patients.
Related Concept Videos
Hypertension I: Introduction
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.

